Publications by authors named "Lynette Phee"

Claim this Profile
A
Atypical microbial keratitis.
Hon Shing Ong, Namrata Sharma, Lynette M Phee, Jodhbir S Mehta

Ocul Surf· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis.
Frank Kloprogge, Julio Ortiz Canseco, Lynette Phee, Zahra Sadouki, Karin Kipper

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbapenemase-producing organism (CPO) colonisation at a district general hospital: universal screening may help reduce transmission.
Lynette Phee, Stephanie Paget, Judy Jacques, Binutha Bharathan, Husam El-Mugamar

Infect Prev Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting.
Zahra Sadouki, Timothy D McHugh, Rob Aarnoutse, Julio Ortiz Canseco, Christopher Darlow, Lynette Phee

J Antimicrob Chemother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital outbreak.
Anand Sivaramakrishnan, Damien Mack, Husam El-Mugamar, Judy Jacques, Stephanie Paget, Lynette Phee

Infect Prev Pract· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response.
David W Wareham, M H F Abdul Momin, Lynette M Phee, Michael Hornsey, Joseph F Standing

J Antimicrob Chemother· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
David W Wareham, M H F Abdul Momin, Lynette M Phee, Michael Hornsey, Joseph F Standing

J Antimicrob Chemother· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam.
Muhd Haziq F Abdul Momin, Apostolos Liakopoulos, David C Bean, Lynette M Phee, David W Wareham

J Antimicrob Chemother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii.
Lynette M Phee, Frank Kloprogge, Rebecca Morris, John Barrett, David W Wareham

J Antimicrob Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.
David W Wareham, Lynette M Phee, Muhd Haziq F Abdul Momin

J Antimicrob Chemother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens.
Muhd Haziq F Abdul Momin, David C Bean, Rene S Hendriksen, Marisa Haenni, Lynette M Phee

J Med Microbiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam.
Muhd Haziq Fikry Abdul Momin, Apostolos Liakopoulos, Lynette M Phee, David W Wareham

J Glob Antimicrob Resist· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Olga Oikonomou, Apostolos Liakopoulos, Lynette M Phee, Jonathan Betts, Dik Mevius

Microb Drug Resist· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae.
David W Wareham, Rishita Shah, Jonathan W Betts, Lynette M Phee, Muhd Haziq F Abdul Momin

J Clin Microbiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
Lynette M Phee, Jonathan W Betts, Binutha Bharathan, David W Wareham

Antimicrob Agents Chemother· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
Jonathan W Betts, Amir S Sharili, Lynette M Phee, David W Wareham

J Nat Prod· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability.
Anne Makena, Jürgen Brem, Inga Pfeffer, Rebecca E J Geffen, Sarah E Wilkins, Lynette M Phee

J Antimicrob Chemother· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Jonathan W Betts, Lynette M Phee, Michael Hornsey, Neil Woodford, David W Wareham

Antimicrob Agents Chemother· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.
Michael Hornsey, Lynette Phee, William Stubbings, David W Wareham

Int J Antimicrob Agents· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase.
Michael Hornsey, Lynette Phee, Neil Woodford, Jane Turton, Daniele Meunier

J Clin Pathol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.
Michael Hornsey, Lynette Phee, Christopher Longshaw, David W Wareham

Int J Antimicrob Agents· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.
Michael Hornsey, Christopher Longshaw, Lynette Phee, David W Wareham

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.
Michael Hornsey, Lynette Phee, David W Wareham

Antimicrob Agents Chemother· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis